Clinical Trial Update: Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated delivering G-Pump glucagon infusion via OmniPod to prevent hypoglycemia in post-bariatric surgery patients; the study was com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complications of Bariatric Procedures
• Hypoglycemia

Drugs mentioned

• G-Pump (glucagon infusion)

Snippet

Sponsor: Xeris Pharmaceuticals | Conditions: Hypoglycemia, Complications of Bariatric Procedures | Phase 2 | Status: COMPLETED | Results posted: 2018-10-30